九典制药：关于吸收合并全资子公司的公告

Core Viewpoint - The company announced its plan to absorb its wholly-owned subsidiary, Hunan Huiyang Information Technology Co., Ltd., which will lead to the cancellation of Huiyang Information's legal status and the transfer of all its assets, debts, and contractual obligations to the company [2]. Group 1 - The board of directors approved the proposal for the absorption merger during the 13th meeting of the 4th board session held on October 23, 2025 [2]. - The merger will not require shareholder approval as it falls within the board's authority [2]. - Following the merger, the company will inherit all rights and obligations of Huiyang Information, including its assets and liabilities [2].